|[December 04, 2013]
Research and Markets: 2014 Analysis of the US Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers and Physician Offices
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/p29lb6/2014_analysis_of)
has announced the addition of the "2014
Analysis of the US Cell Surface Marker Testing Market: Hospitals,
Commercial Labs, Ambulatory Care Centers, Physician Offices"
report to their offering.
The use of surface marker identification and classification of cells is
spreading beyond lymphocytes to the identification of monocytes,
macrophages, myeloid stem cells, and tumor cells. A synergistic
combination of the hybridoma technology with flow cytometry is further
expanding the applications of both technologies. During the next ten
years, the main trnd in cell surface marker analysis will be further
simplification of the sample preparation and the analysis itself.
This report presents a detailed overview of the CD4, CD8 and CD34 Cell
Surface Marker testing in the US, including clinical significance and
current laboratory practice, as well as five-year test volume forecasts
by market segment.
The report examines market applications of monoclonal antibodies, IT,
DNA probes, biochips/microarrays, and other technologies; reviews
features and operating characteristics of automated analyzers; profiles
leading suppliers and recent market entrants developing innovative
technologies and products; and identifies alternative market penetration
strategies and entry barriers/risks.
-Beckman Coulter/Danaher (News - Alert)
-Siemens (News - Alert)
For more information visit http://www.researchandmarkets.com/research/p29lb6/2014_analysis_of
About Research and Markets
Research and Markets is the world's leading source for international
market research reports and market data. We provide you with the latest
data on international and regional markets, key industries, the top
companies, new products and the latest trends.
[ Back To Technology News's Homepage ]